Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical cannabidiol gel for hand osteoarthritis pain
ACTRN12621001512819Phase 2Completed
- Sponsor
- Avecho Biotechnology
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cannabidiol in hand osteoarthritis, sponsored by Avecho Biotechnology. Primary endpoint: Change in hand pain. Started Feb 2022; status: completed.
02
Drugs
cannabidiol
03
Conditions
hand osteoarthritis
Beyond the preview
Go deeper on ACTRN12621001512819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621001512819.